These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 23232578)
1. Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma. Fransson S; Abel F; Kogner P; Martinsson T; Ejeskär K Int J Oncol; 2013 Feb; 42(2):609-16. PubMed ID: 23232578 [TBL] [Abstract][Full Text] [Related]
2. High level of p37δ-mRNA relative to p110δ-mRNA in neuroblastoma tumors correlates with poor patient survival. Fransson S; Ejeskär K Med Oncol; 2013 Dec; 30(4):724. PubMed ID: 24026661 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma. Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319 [TBL] [Abstract][Full Text] [Related]
4. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas. Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588 [TBL] [Abstract][Full Text] [Related]
5. Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells. Boller D; Schramm A; Doepfner KT; Shalaby T; von Bueren AO; Eggert A; Grotzer MA; Arcaro A Clin Cancer Res; 2008 Feb; 14(4):1172-81. PubMed ID: 18281552 [TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2. Fransson S; Martinsson T; Ejeskär K Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas. Takahashi M; Ozaki T; Todo S; Nakagawara A Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504 [TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma]. Zhang Y; Liu YP; Du K; Wang H; Wang XL Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219 [TBL] [Abstract][Full Text] [Related]
9. Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas. Fransson S; Kogner P; Martinsson T; Ejeskär K J Mol Signal; 2013 Apr; 8(1):4. PubMed ID: 23597230 [TBL] [Abstract][Full Text] [Related]
10. Analysis of PI3K/AKT/mTOR signalling pathway in high risk neuroblastic tumours. Iżycka-Świeszewska E; Drożyńska E; Rzepko R; Kobierska-Gulida G; Grajkowska W; Perek D; Balcerska A Pol J Pathol; 2010; 61(4):192-8. PubMed ID: 21290341 [TBL] [Abstract][Full Text] [Related]
11. p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors. Fransson S; Uv A; Eriksson H; Andersson MK; Wettergren Y; Bergo M; Ejeskär K Oncogene; 2012 Jul; 31(27):3277-86. PubMed ID: 22020336 [TBL] [Abstract][Full Text] [Related]
12. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429 [TBL] [Abstract][Full Text] [Related]
13. PI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions. Gómez-Villafuertes R; García-Huerta P; Díaz-Hernández JI; Miras-Portugal MT Sci Rep; 2015 Dec; 5():18417. PubMed ID: 26687764 [TBL] [Abstract][Full Text] [Related]
14. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression. Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392 [TBL] [Abstract][Full Text] [Related]
15. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest. Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613 [TBL] [Abstract][Full Text] [Related]
16. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas. Zhang J; Zheng Y; Wang Y; Tong H J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105 [TBL] [Abstract][Full Text] [Related]
17. Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489 [TBL] [Abstract][Full Text] [Related]
18. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma. Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786 [TBL] [Abstract][Full Text] [Related]
19. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma. Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080 [TBL] [Abstract][Full Text] [Related]
20. Studies on the expression patterns of class I PI3K catalytic subunits and its prognostic significance in colorectal cancer. Cui B; Tao J; Yang Y Cell Biochem Biophys; 2012 Jan; 62(1):47-54. PubMed ID: 21910030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]